surmount-4 tirzepatide withdrawal weight regain for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial PDF) Cardiometabolic Parameter Change by
Description
Appetite suppression lowers calorie and protein intake

Tirzepatide may be helpful for some patients who are dealing with weight gain, insulin resistance, blood sugar concerns, or weight-related cardiovascular risk factors

The tirzepatide weight loss timeline typically shows measurable results within the first four to eight weeks, with the most dramatic changes occurring between months three and six as doses titrate upward

Contraindications and Safety Precautions Tirzepatide is not suitable for everyone

Heres what to watch: monitor blood pressure weekly during the first few months, especially if youre already on antihypertensives
